The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006 and is described as a smart beta ETF providing broad exposure to the Health Care ETFs category. The article is purely descriptive and contains no performance, flow, or event-driven catalyst. No material market impact is implied.
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006 and is described as a smart beta ETF providing broad exposure to the Health Care ETFs category. The article is purely descriptive and contains no performance, flow, or event-driven catalyst. No material market impact is implied.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.05
